GE Fanuc Automation life sciences expert to speak at INTERPHEX 2007

Discussion will cover a real world example of a PAT Solution Using ProficyTM RX

April 20, 2007 — CHARLOTTESVILLE, VA — GE Fanuc Automation, a unit of GE Industrial, today announced that Bart Reitter, GE Fanuc global industry manager, life sciences, would be speaking at INTERPHEX 2007, being held at the Jacob Javits Convention Center in New York City, April 24-26, 2007. Reitter’s presentation will discuss “PAT: A Real World Successful Drying Application.” The session will take place on Wednesday, April 25 from 9:00 to 10:00 a.m.

This session will be a discussion of a successful deployment of GE Fanuc’s PAT Solution deployed to deliver measurable results to a contract manufacturer of bulk active pharmaceuticals and advanced intermediates. Outcome of the project includes enhanced visibility into the drying process and a dramatic reduction in product drying time.

Reitter will be sharing the podium with GE Fanuc customer John Iapichino, instrument and controls engineer for AMRI/Organichem Corporation, who is using GE Fanuc’s ProficyTM RX, PAT software solution.

“As PAT deployments grow,” said Reitter, “so do the number of instruments and software applications. The quantity and type of data also grows significantly. It is imperative that organizations have a robust data infrastructure to support those deployments. Consideration needs to be given not only to spectral data acquired from the instrument, but also to process, batch, alarm and event data as well. With the goal of PAT being a comprehensive understanding of the process, it is important to build out a data infrastructure that can acquire, store and analyze all of that disparate data.”

GE Fanuc is a leader in providing manufacturing solutions to the life sciences industry. The company’s PAT offering, comprised of ProficyTM RX, ProficyTM Historian, ProficyTM HMI/SCADA iFIX and ProficyTM Real Time Information Portal is a unique software solution that provides standardized control and networking of multiple instruments, preprocessing of analytical data ensuring similar data formats and protocols, robust storage of process, spectral, batch, alarm and event data, operator interface capability and reporting and analysis tools.

GE Fanuc will be exhibiting at INTERPHEX 2007 in Booth 2300.

About INTERPHEX 2007
INTERPHEX 2007 is the world’s largest and most comprehensive pharmaceutical conference and exhibition. It is presented by Reed Exhibitions and sponsored by ISPE, the international society for pharmaceutical engineering, and Pharmaceutical Processing magazine. The application-oriented INTERPHEX 2007 conference program will offer more than 100 separate educational sessions to help
pharmaceutical and biotech professionals develop critical skills to increase on-the-job performance. Approximately 1000 leading global companies serving pharmaceutical and biotechnical industries will showcase the latest lines of equipment, technologies and services.

About GE Fanuc Automation
GE Fanuc Automation Corporation, a joint venture between GE and FANUC LTD of Japan, delivers automation hardware and software designed to help users reduce costs, increase efficiency and enhance profitability. With solutions and services for virtually every industrial segment, GE Fanuc Automation provides a diverse array of capabilities and products, including controllers, embedded systems, advanced software, motion control, CNCs, operator interfaces, industrial computers, and lasers. Headquartered in Charlottesville, VA, GE Fanuc Automation is a part of GE Industrial and combines the diverse global strengths of the GE family with the local presence customers need to design, develop and maintain their automation investments.

For more information, visit or contact: GE Fanuc Information Center
P.O. Box 8106
Charlottesville, VA 22906
800-GE-FANUC (800-433-2682)
Fax: 434-978-5205
e-mail: [email protected].


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.